Deal Announcement

goetzpartners advised Silverfleet Capital

goetzpartners conducted the commercial due diligence of 7days for Silverfleet Capital

Due Diligence
Healthcare and Life Sciences
Transaction
2017
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Silverfleet Capital on the

Commercial Due Diligence

in the acquisition of 7days

Silverfleet Capital, the Pan-European private equity firm that specialises in buy-to-build, has entered into a binding contract with Odewald KMU and the founders to acquire a majority stake in the 7days group (“7days” or the “Company”), a leading designer, manufacturer and supplier of medical workwear. The founders will reinvest alongside Silverfleet Capital and remain with the Company.

 

Founded in 1999 by Marc Staperfeld and Ulrich Doelken and based in Lotte, Germany, 7days is a vertically integrated online and mail order business, which supplies clothing and accessories to the healthcare industry, specifically medical practices and dentists.

 

The Company offers a comprehensive product portfolio designed exclusively for medical professionals that includes tunics, tops (polo shirts, sweatshirts etc.), trousers, lab coats, shoes and accessories. 7days continuously tailors its portfolio, which currently comprises over 2,600 products, to customer requirements and offers a high degree of customisation with a focus on quality and value for money. The Company’s design studio and procurement departments are based in Lotte, Germany with production facilities in Tangier, Morocco.

 

About Silverfleet Capital

Silverfleet Capital has been an active European mid-market private equity investor for more than 30 years. The investment team of 28 executives is based in London, Munich, Paris and Stockholm and currently manages around €1.2 billion. Silverfleet Capital’s second independent fund closed in 2015 with commitments of €870 million.

 

Transaction team

 

Dr. Sigurd Kitzer
Partner
 

Gerrit Daute
Manager
 

Alicia Brehm
Associate Consultant

 

Stephan Schömer
Associate Consultant

 

Martin Schießl
Associate Consultant

More transactionsYou might also be interested in...

2024
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Ethica Global Investments S.p.A with a

Commercial Due Diligence

on the acquisition of RP Group

2024
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Mipharm S.p.a., a portfolio company of Alto Partners SGR, with a

Commercial Due Diligence

on the merger with Doppel Farmaceutici S.r.l., a portfolio company of Trilantic Europe

2022
Icon: flag-ITIcon: flag-IT

goetzpartners advised

F2i SGR S.p.A. with a

Commercial Due Diligence

on the acquisition of Althea

2022
Icon: flag-FRIcon: flag-IT

goetzpartners advised

LBO France Gestion SAS with a

Commercial Due Diligence

on the acquisition of Astidental di Sabbione S.p.A.

2021
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Itago SGR S.p.A. with a

Commercial Due Diligence

on the acquisition of Operamed S.r.l.

2020
Icon: flag-GBIcon: flag-IT

goetzpartners advised

Neuberger Berman AIFM Sarl with a

Commercial Due Diligence

on the acquisition of Bluvet S.r.l.

2020
Icon: flag-FRIcon: flag-IT

goetzpartners advised

LBO France Gestion SAS with a

Commercial Due Diligence

goetzpartners advised LBO France Gestion SAS with a

2020
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Arcadia SGR S.p.A. with a

Commercial Due Diligence

on the acquisition of Favillini S.r.l. and Ideagrafica S.r.l.

2019
Icon: flag-FRIcon: flag-IT

goetzpartners advised

ArchiMed SAS with a

Commercial Due Diligence

on the acquisition of DIESSE Diagnostica Senese S.p.A.

2019
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Alto Partners SGR S.p.A. with a

Commercial Due Diligence

on the acquisition of OFI Officina Italiana Farmaceutica S.p.A.

2018
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Gimv on the

Commercial Due Diligence

in the acquisition of Medi-Markt GmbH

2017
Icon: flag-DEIcon: flag-CH

goetzpartners advised

ECM Equity Capital Managementcon the

Commercial Due Diligence

in the acquisition of Uroviva Group

2016
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Mandarin Capital Partners with a

Commercial Due Diligence

on the acquisition of Mipharm S.p.A.